bioAffinity Technologies
BIAF | NASDAQ
$2.00
-$0.20 (-9.09%)
At close: Nov 16, 2026, 4:00 PM ET
$2.10
+$0.10 (+5.00%)
After-hours:
Nov 16, 2026, 7:34 PM ET
bioAffinity Technologies Company Profile
Company profile explainedCompany Profile
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Key Executives
| Name | Position |
|---|---|
| Maria Zannes | Founder, President, Chief Executive Officer & Director |
| James Michael Edwards | Chief Financial Officer |
| Xavier T. Reveles | Chief Operating Officer |
| Dallas J. Coleman | Vice President of sales |
| Gordon Downie | Chief Medical Officer |
| Julie Anne Overton | Director of Communications |
| Steven Girgenti | Founder & Executive Chairman of the Board |
| Timothy Zannes | Executive Vice President, Secretary & General Counsel |
| William Bauta | Chief Science Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 8-K | Current Report |
| Oct 23, 2026 | DEF 14A | Filing |
| Oct 15, 2026 | 8-K | Current Report |
| Oct 13, 2026 | 8-K | Current Report |
| Oct 13, 2026 | PRER14A | Filing |
| Oct 09, 2026 | 8-K | Current Report |
| Oct 09, 2026 | 424B5 | Filing |
| Oct 09, 2026 | 424B5 | Filing |
| Oct 08, 2026 | 8-K | Current Report |
| Oct 06, 2026 | 8-K | Current Report |
bioAffinity Technologies
| Country | United States |
| IPO Date | Sep 1, 2022 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Maria Zannes |
Contact Details
3300 Nacogdoches Road San Antonio,
Texas 78217 United States
Stock Details
| Ticker Symbol | BIAF |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001712762 |
| CUSIP Number | 09076W406 |
| ISIN Number | US09076W4069 |
| SIC Code | 8731 |
Add to Watchlist
Select watchlists to add or remove BIAF